Denmark · 
Who invested in Hemab Therapeutics?
Hemab Therapeutics's investors include Access Industries, RA Capital Management, Novo Holdings, Invus and Rock Springs Capital, and 4 more on record. Access Industries led its latest round.
Denmark · Series B startup
Who invested in Hemab Therapeutics
One round we have observed, with the 9 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$135Mraised across 1 round since 2023, from 1 source
- Latest round
- Series B, $135MFeb 2023
- Led by
- Access Industries
- Investors
- 9 (1 led)
The rounds
- Feb 2023
Everyone who backed them
Maj Invest EquityVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Hemab Therapeutics
How much has Hemab Therapeutics raised?
Hemab Therapeutics has raised $135M across 1 round since 2023.
When did Hemab Therapeutics last raise?
Hemab Therapeutics's most recent round was a Series B of $135M in Feb 2023, led by Access Industries.
What was Hemab Therapeutics's biggest round?
Its most recent round, $135M in Feb 2023, is also its largest on record.
Who backed Hemab Therapeutics first?
Hemab Therapeutics's first round on record, in Feb 2023, was backed by Access Industries, RA Capital Management and Novo Holdings and 6 others.
What stage is Hemab Therapeutics at?
Hemab Therapeutics's latest named round is a Series B, in Feb 2023.
Where is Hemab Therapeutics based?
Hemab Therapeutics is based in Denmark.
Who led Hemab Therapeutics's rounds?
Access Industries led the Series B in 2023.
Companies like Hemab Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.